iifl-logo

Medicamen Biotech Ltd Share Price

493.55
(2.82%)
Apr 1, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open472
  • Day's High495.35
  • 52 Wk High630
  • Prev. Close480
  • Day's Low465.7
  • 52 Wk Low 375.05
  • Turnover (lac)191.06
  • P/E60.36
  • Face Value10
  • Book Value170.08
  • EPS7.98
  • Mkt. Cap (Cr.)627.53
  • Div. Yield0.21
View All Historical Data
No Records Found

Medicamen Biotech Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

472

Prev. Close

480

Turnover(Lac.)

191.06

Day's High

495.35

Day's Low

465.7

52 Week's High

630

52 Week's Low

375.05

Book Value

170.08

Face Value

10

Mkt Cap (₹ Cr.)

627.53

P/E

60.36

EPS

7.98

Divi. Yield

0.21

Medicamen Biotech Ltd Corporate Action

26 Feb 2025

12:00 AM

EGM

arrow

10 Sep 2024

12:00 AM

AGM

Announcement Date: 10 Sep, 2024

arrow

21 Feb 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

29 May 2024

12:00 AM

Dividend

Dividend Amount: 1

Record Date: 19 Sep, 2024

arrow

16 Aug 2024

12:00 AM

BookCloser

arrow

Medicamen Biotech Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Medicamen Biotech Ltd SHAREHOLDING SNAPSHOT

02 Apr, 2025|08:43 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 42.99%

Foreign: 0.00%

Indian: 42.99%

Non-Promoter- 0.98%

Institutions: 0.97%

Non-Institutions: 56.03%

Custodian: 0.00%

Share Price

Medicamen Biotech Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

12.71

13.78

12.22

12.22

Preference Capital

0

0

0

0

Reserves

196.49

180.02

135.82

122.14

Net Worth

209.2

193.8

148.04

134.36

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

110.14

117.34

111.5

82.45

yoy growth (%)

-6.13

5.23

35.23

22.56

Raw materials

-66.87

-72.95

-67.65

-49.2

As % of sales

60.71

62.17

60.67

59.67

Employee costs

-8.79

-9.29

-9.05

-6.65

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

16.75

16.6

13.9

6.35

Depreciation

-2.51

-2.49

-2.05

-1.92

Tax paid

-4.26

-4.34

-3.78

-1.19

Working capital

-1.38

-8.09

38.28

6.51

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-6.13

5.23

35.23

22.56

Op profit growth

10.23

7.79

49.71

119.69

EBIT growth

3.74

5.29

73.66

146.26

Net profit growth

1.85

21.22

95.97

973.02

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

179.31

140.87

115.45

112.72

125.5

Excise Duty

0

0

0

0

0

Net Sales

179.31

140.87

115.45

112.72

125.5

Other Operating Income

0

0

0

0

0

Other Income

2.33

2.46

1.72

0.75

1.94

Medicamen Biotech Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,698.35

129.244,07,155.151,181.050.85,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,549.7

71.051,47,295.245940.542,297513.62

Cipla Ltd

CIPLA

1,444.25

25.071,16,664.331,438.150.94,134.87360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,183.9

59.031,07,673.274850.882,330222.38

Mankind Pharma Ltd

MANKIND

2,458.1

52.421,01,358.17416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Medicamen Biotech Ltd

Management

Register Office

Registrar Office

Non Executive Director

Sanjay Bansal

Chairman (Non-Executive)

Rahul Bishnoi

Non Executive Director

Ashwani Kumar Sharma

Independent Director

Harish Pande

Non Executive Director

S K Singh

Independent Director

Arun Kumar

Company Sec. & Compli. Officer

Parul Choudhary

Independent Director

Sumita Dwivedi

Non Executive Director

Vimal Kumar Shrawat.

Independent Director

Sangeeta Bishnoi

Independent Director

Ravi Kumar Bansal

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets. The Company has presence in 40+ countries. Its offerings include Finished Dosage Forms (FDFs) to African countries. In India, MBL is among the leading companies in oncology segment with its own sales force and a branding team that has helped garner a strong foothold in the domestic market. MBL has three pharma formulation facilities including two in Haridwar (Uttarakhand), one in Bhiwadi (Rajasthan). The Company manufactures products across various therapeutic categories including Pain Management, Cough & Cold, Cardiovascular & Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic among others.The Bhiwadi unit has ultra modern production facilities incorporating latest state of the art technology with a combination of technically qualified personnel and hardworking workforce. In Haridwar unit, the company manufactures Non-Betalactum preparations including tablets, capsules, oral liquids and ointments & creams.Medicamen Biotech Limited was incorporated in December, 1993 and started their operation as distributor and manufacturer of medicines on loan license basis. The distribution activities were spread manifold over a wide market extending beyond the domestic market and started exporting to CIS countries.The vast distribution network
Read More

Company FAQs

What is the Medicamen Biotech Ltd share price today?

The Medicamen Biotech Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹493.55 today.

What is the Market Cap of Medicamen Biotech Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Medicamen Biotech Ltd is ₹627.53 Cr. as of 01 Apr ‘25

What is the PE and PB ratio of Medicamen Biotech Ltd?

The PE and PB ratios of Medicamen Biotech Ltd is 60.36 and 2.78 as of 01 Apr ‘25

What is the 52 Week High and Low of Medicamen Biotech Ltd?

The 52-week high/low is the highest and lowest price at which a Medicamen Biotech Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Medicamen Biotech Ltd is ₹375.05 and ₹630 as of 01 Apr ‘25

What is the CAGR of Medicamen Biotech Ltd?

Medicamen Biotech Ltd's CAGR for 5 Years at -2.21%, 3 Years at -10.16%, 1 Year at 23.79%, 6 Month at -15.71%, 3 Month at -2.31% and 1 Month at 2.80%.

What is the shareholding pattern of Medicamen Biotech Ltd?

The shareholding pattern of Medicamen Biotech Ltd is as follows:
Promoters - 42.99 %
Institutions - 0.97 %
Public - 56.04 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.